Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1987 Mar;46(3):263. doi: 10.1136/ard.46.3.263

Serum lactic dehydrogenase as a marker of joint damage in rheumatoid arthritis.

P W Thompson, D D Jones
PMCID: PMC1002115  PMID: 3579395

Full text

PDF

Page 263

263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dawes P. T., Fowler P. D., Jackson R., Collins M., Shadforth M. F., Stone R., Scott D. L. Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy. Ann Rheum Dis. 1986 Nov;45(11):945–949. doi: 10.1136/ard.45.11.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Thompson P. W., Jones D. D., Currey H. L. Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis. Ann Rheum Dis. 1986 Jan;45(1):9–14. doi: 10.1136/ard.45.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. VESELL E. S., OSTERLAND K. C., BEARN A. G., KUNKEL H. G. Isozymes of lactice dehydrogenase; their alterations in arthritic synovial fluid and sera. J Clin Invest. 1962 Nov;41:2012–2019. doi: 10.1172/JCI104659. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES